Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TRMT13 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SNAP23 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DOCK5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
USP38 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TTYH2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
NPC1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MAN2A2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATP11A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CYP2J2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SALL1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TMEM165 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SGMS1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RAP1A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATL3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SEL1L2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
LAMP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PARP4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MON2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PXK - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on